🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Free and open to all! Come along to our webinar for an update on @STRAVINSKYStudy’s progress so far. ✅Hear the latest on #COVID19 immunity in clinically vulnerable people ✅See how you could get involved ⏲️18:00-19:00, Weds 24 April 🔗immunology.org/events/update-… Professor Alex Richter

Fantastic talk #OlivierHermine #EBMT24 👏👏 GI T cell lymphoma Access to CD30-directed immunotherapy (BV)? Role of BEAM auto-SCT consolidation? BV maintenance in ‘more frail’ RCDII insight & interventions Ongoing studies

So excited to announce that the resveratrol trial within COLO-PREVENT Trial is now open. It's taken us about 20 years of research University of Leicester to get to this point. Thanks to everyone who had been involved.Research at Leicester's Hospitals Leicester Clinical Trials Unit 𝗗𝗿 𝗔𝗷𝗮𝘆 𝗠 𝗩𝗲𝗿𝗺𝗮 mark hull Barry Sandywell Lynne Howells

Brilliant UK effort. Congratulations

Day 2 of #MSKLymphomaSymposium Masterclass in CNS lymphoma by Kate Cwynarski -MTX based induction -thiotepa based transplant consolidation (fit older pts too) MSK Department of Medicine MSK CME Women in Lymphoma - [email protected]

BCL2 inhibition: back to the future! ashpublications.org/blood/article/… "God is in the detail". Fantastic commentary, penned by two esteemed colleagues, delving into Liu et al's report on the preliminary characterization of the new BCL2-specific inhibitor sonrotoclax. #lymsm

Fantastic work. Estimated that 50% of CH driver genes in blood now identified!! MYD88 data interesting - recurrently mutated but not under strong selection (lack of fitness), which is somewhat surprising.

Join us this Blood Cancer Awareness Month, for Lymphoma Management 2024! This course for healthcare professionals covers key topics for the effective management of lymphomas. 📅 9-10 September 📍 Oxford 🎫early bird rate 🔎 More info: lymphoma-action.org.uk/LymphomaManage… #LymSM #Haematology

Book now - early bird rate available until Monday 24 June! Are you a healthcare professional working in #Lymphoma or looking to develop your interest? Join us for Lymphoma Management: 📅 9-10 September 📍 Oxford 🔎 Find out more: lymphoma-action.org.uk/LymphomaManage… #LymSM #Haematology

STRAVINSKY is recruiting patients with #sicklecellanemia to understand risk of #covid and other infections. Can attend in person if Birmingham, Southampton, Imperial or Oxford patient or can do a finger prick at home for an antibody test off prefer or based elsewhere in UK

Professor Jessica Okosun, FLF Scientific Advisor, highlights the importance of follicular lymphoma (FL) clinical trials for all stages of a patient’s journey.   ​ ​Watch the full webinar here:​ theflf.org/previous-webin…

BSH Lymphoma SIG MDT Dilemmas Live webinar Thurs 10Oct 1800-19:30 Management of asymp low tumour burden FL: Kirit Ardeshna & David Tucker Rx PMBL Andy Davies & ⁦Nicolas Martinez 🇨🇴🇨🇴⁩ NLPHL Rx dilemmas ⁦Pam McKay⁩ ⁦⁦Graham Collins⁩ b-s-h.org.uk/education/conf…

Last chance to apply for two Haematology NIHR Academic Clinical Fellowship (ACF) posts at Leicester 1. Determinants of response to immunotherapeutic strategies in aggressive lymphomas 2. Liquid biopsy for aggressive lymphomas le.ac.uk/clinical-acade… National Institute for Health and Care Research

Delighted to participate in this clinical trial: encouraging/durable responses Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study - The Lancet Oncology thelancet.com/journals/lanon…

STRAVINSKY is still open for recruitment. We are still looking for participants with certain conditions that affect their immune system to join our study & help us find out more about COVID infection risk. You can more info on our website⬇️ immunology.org/partnerships/s…

Having learned every BSH - Haematology guideline off by heart for my FRCPath, it was very exciting to have been afforded the opportunity to lead an amazing group of co-authors for our GPP regarding bleomycin use in Hodgkin Lymphoma- published today! onlinelibrary.wiley.com/doi/10.1111/bj…

Huge thanks to the 200 people who have volunteered to be part of the STRAVINSKY study here in Leicester. This large study has been looking at people with conditions that affect their immune system to help find out more about their specific COVID infection risk. Well done to